Commercializing Innovation

Turning scientific breakthroughs into long-term commercial success requires more than great ideas—it demands the infrastructure, strategy, and discipline to scale them. In this conversation with Oliver Stauffer, CEO of PTI, we explore how critical packaging is to the integrity and safety of life science products as they travel through complex supply chains. As “the final line of defense,” packaging technologies play a central role in ensuring that therapies reach patients and consumers exactly as intended. Gain insight into what it takes to build and maintain a culture of innovation, especially in organizations striving to bridge scientific and commercial worlds. Stauffer also underscores the growing need for regulatory clarity from FDA as new modalities emerge.

Dive into the full discussion to gain practical perspective from an industry leader.